Clinical Trials Browser

Phase 1/2 × Recruiting × Zoledronic Acid × Clear all

Chordoma, Myoepithelioma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Nerve Sheath Neoplasms, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

NCT06374459 2026-02-09

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Phase 1/2 Recruiting

152 enrolled

Breast

Breast Neoplasms

NCT06759064 2025-11-19

IPIZA

Phase 1/2 Recruiting

24 enrolled

Gastrointestinal

Adenocarcinoma, Ascites, Stomach Neoplasms

Clinical Trials

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

IPIZA